This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Vifor Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Key information
13.6%
Debt to equity ratio
CHF540.20m
Debt
Interest coverage ratio | -377.5x |
Cash | CHF993.60m |
Equity | CHF3.97b |
Total liabilities | CHF1.13b |
Total assets | CHF5.10b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GNHA.F's short term assets (CHF1.9B) exceed its short term liabilities (CHF981.3M).
Long Term Liabilities: GNHA.F's short term assets (CHF1.9B) exceed its long term liabilities (CHF149.2M).
Debt to Equity History and Analysis
Debt Level: GNHA.F has more cash than its total debt.
Reducing Debt: GNHA.F's debt to equity ratio has reduced from 86.5% to 13.6% over the past 5 years.
Debt Coverage: GNHA.F's debt is well covered by operating cash flow (97.6%).
Interest Coverage: GNHA.F earns more interest than it pays, so coverage of interest payments is not a concern.